Axsome to seek approval of AXS-05 to treat agitation in Alzheimer's disease
The company recently announced results from two Phase 3 trials of AXS-05 for agitation. ACCORD-2, hit its main goal, but ADVANCE-2 didn't.| Alzheimer's News Today
The company recently announced results from two Phase 3 trials of AXS-05 for agitation. ACCORD-2, hit its main goal, but ADVANCE-2 didn't.| Alzheimer's News Today
Columnist Ray Burow, grieving the loss of her dear friend Richard Allen Farmer, reflects on how he cared for her mother, who had Alzheimer's.| Alzheimer's News Today
Early-onset Alzheimer's is a rare form of dementia that occurs between ages 30 and 60, and may affect several members of a single family.| Alzheimer's News Today
Marisa Wexler is a senior science writer for Alzheimer's News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of Alzheimer's topics.| Alzheimer's News Today
Columnist Ray Burow explains how her mother's Alzheimer's called to mind Dickens' quote about the "spring of hope" and "winter of despair."| Alzheimer's News Today
Diagnosis of Alzheimer's disease involves assessing patients' medical history, symptoms, lab tests, and using brain imaging to rule out other conditions.| Alzheimer's News Today
No description.| Alzheimer's News Today
Category archive page for News.| Alzheimer's News Today
Learn more about Alzheimer's disease, the most common cause of dementia and an irreversible, progressive neurological disorder.| Alzheimer's News Today
